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The obligate anaerobe Bacteroides fragilis is a normal resident of the human gastrointestinal tract.
The clinically derived B. fragilis strain NCTC 9343 produces an extensive array of extracellular
polysaccharides (EPS), including antigenically distinct large, small and micro- capsules. The
genome of NCTC 9343 encodes multiple gene clusters potentially involved in the biosynthesis of
EPS, eight of which are implicated in production of the antigenically variable micro-capsule. We
have developed a rapid and robust method for generating marked and markerless deletions,
together with efficient electroporation using unmodified plasmid DNA to enable complementation
of mutations. We show that deletion of a putative wzz homologue prevents production of high-
molecular-mass polysaccharides (HMMPS), which form the micro-capsule. This observation
suggests that micro-capsule HMMPS constitute the distal component of LPS in B. fragilis. The
long chain length of this polysaccharide is strikingly different from classical enteric O-antigen,
which consists of short-chain polysaccharides. We also demonstrate that deletion of a putative
wbaP homologue prevents expression of the phase-variable large capsule and that expression
can be restored by complementation. This suggests that synthesis of the large capsule is
mechanistically equivalent to production of Escherichia coli group 1 and 4 capsules.
INTRODUCTION
Encapsulating polysaccharides surrounding bacteria have
diverse roles in protecting the cell against environmental
insults, for example prevention of desiccation, resistance to
bacteriophage infection, and avoidance of host immune
systems (Sutherland, 1977). Capsule production in
Escherichia coli is the paradigm for understanding the
genetics and biochemistry of extracellular polysaccharide
(EPS) production. In both E. coli and Salmonella enterica,
polysaccharide biosynthetic genes are clustered together for
the production of either the O-antigen of lipopolysacchar-
ide (LPS) or capsular polysaccharides (groups 1, 2, 3 and 4;
reviewed by Whitfield, 2006). Polysaccharides required for
the production of LPS and capsules of groups 1 and 4 are
transported across the inner membrane and polymerized
by specific Wzx (flippase) and Wzy (polymerase) proteins,
respectively. However, the fate of the polysaccharide is
dictated by subsequent protein partners, which either ligate
the polysaccharide to lipid A-core (WaaL for LPS and KLPS
production) or transport it directly beyond the outer
membrane (Wza for capsular polysaccharides). In contrast,
group 2 and 3 capsular polysaccharides are synthesized by
processive glycosyltransferases and exported via an ABC
transporter system. Despite the large number of serotypes
found in E. coli, there is generally little intra-strain variation
in capsular types; for example, a strain will only produce a
single group 1 capsule, and not multiple variants, because
there is only one polysaccharide biosynthetic locus present
in the chromosome. The exception is colanic acid, which
may be co-expressed with group 2 capsules (Whitfield,
2006). Where intra-strain antigenic variation does occur,
two different polysaccharides may be generated by modi-
fication of the polysaccharide sugar moieties, for example by
acetylation (Vimr & Steenbergen, 2006).
In contrast, the genome of Bacteroides fragilis NCTC 9343
contains ten annotated regions (PS A–J) implicated, by
homology, in EPS production (Cerden˜o-Ta´rraga et al.,
2005). PS loci A–I contain genes predicted to encode Wzx
and Wzy proteins, suggesting that these polysaccharides
will either be linked to lipid A-core prior to export or be
secreted directly beyond the outer membrane. However,
there are no annotated homologues for WaaL and only one
potential Wza homologue can be found in the genome.
Abbreviations: EPS, extracellular polysaccharide(s); HMMPS, high-
molecular-mass polysaccharide; IFM, immunofluorescence microscopy;
LC, large capsule; MC, micro-capsule; PCP, polysaccharide copolymer-
ase; R/M, restriction/modification; SC, small capsule.
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B. fragilis is the Gram-negative obligately anaerobic
member of the normal human intestinal microbiota most
frequently isolated from opportunistic infections (Patrick,
2002; Patrick & Duerden, 2006). Infections include
peritonitis, serious gynaecological sepsis, soft tissue abscess
and bacteraemia. The latter has an estimated mortality of
19% (Redondo et al., 1995). Potential virulence determi-
nants include expression of within-strain phase and
antigenically variable polysaccharides that form a marginal
electron-dense layer, or micro-capsule (MC), of approxi-
mately 35 nm in size, outwith the outer membrane and not
visible by light microscopy (Fig. 1; Patrick et al., 1986;
Lutton et al., 1991). Of the eight PS loci (A–H) that are
related to variable MC expression, seven are switched ON
and OFF by the site-specific inversion of promoter
sequences, where recombination can be mediated by two
members of the serine family of invertases (Patrick et al.,
2003; Coyne et al., 2003; Liu et al., 2008). In addition to
MCs, antigenically distinct and within-strain variable large
capsules (LCs) and small capsules (SCs) are visible by light
microscopy when cultures are grown in a glucose-defined
medium (Fig. 1; Patrick et al., 1986), for which the gene
loci remain to be assigned. Populations of B. fragilis
enriched for the different capsules can be obtained by using
Percoll density-gradient centrifugation. The antigenically
variable MCs are co-expressed with the LC; an electron-
dense layer adjacent to the outer membrane is visible
beneath the LC by electron microscopy, and reactivity with
MC-specific mAbs is demonstrable by immunofluores-
cence microscopy (Fig. 1; Lutton et al., 1991; Patrick,
1993). With continuous daily subculture these populations
gradually revert to mixed capsular types. The LC confers
resistance to phagocytic uptake and killing by human
polymorphonuclear leukocytes in vitro (Reid & Patrick
1984), whereas MC-enriched populations are phagocytosed
and killed. The MC is also important for colonization of
the mammalian gastrointestinal tract. Recent evidence
suggests that a single polysaccharide is sufficient to allow
effective competition of a mutant strain with wild-type B.
fragilis when co-inoculated into a gnotobiotic mouse
(Coyne et al., 2008). This finding, however, is contradicted
by other evidence that suggests strains expressing a single
polysaccharide are not competitive in the gastrointestinal
tract (Liu et al., 2008).
Genetic manipulation of many bacteria, including clinically
relevant B. fragilis strains, has been problematic largely
because of the restriction/modification (R/M) systems that
recognize and cleave foreign DNA, which has usually been
prepared from an E. coli host (Salyers et al., 2000). B.
fragilis NCTC 9343 contains a shufflon that can generate
eight different HsdS proteins that provide DNA target
specificity for a type I R/M system, plus two further type I
and two type III R/M systems (Cerden˜o-Ta´rraga et al.,
2005). Production of mutations in some strains of B.
fragilis, often the 638R background, has been reported. One
method relies on integration of the altered sequence into
the chromosome followed by screening for spontaneous
resolution of the diploid to yield the desired product
(Coyne et al., 2003, 2008). This approach can be time
consuming and does not always produce the required
mutant if the diploid is stable. An alternative approach uses
resistance to trimethoprim, conferred by a chromosomal
thyA mutation in B. fragilis, to select for resolution of
diploids where the suicide plasmid carries a functional
copy of thyA (Baughn & Malamy, 2002). While this
method enriches resolved diploids, it has the drawback that
the strain to be engineered must first be made trimetho-
prim resistant and so all resulting strains contain a thyA
mutation, which may have undesirable consequences for
further studies. For example, a thyA mutation in E. coli will
induce the SOS response if the cells are not provided with
exogenous thymine (Begg & Donachie, 1978). Here we
describe and validate a new and robust method for
generating deletion mutants, and the complementation
thereof, in B. fragilis NCTC 9343. This technique enables
the rapid and reliable production of mutants that are either
marked with an antibiotic resistance determinant or are
Fig. 1. LC, SC and MC populations of B.
fragilis prepared by discontinuous Percoll
density-gradient centrifugation. (a) Light
micrographs of negative capsule stain. (b)
Transmission electron micrographs of ultrathin
sections. (c, d) Immunofluorescence micro-
graphs of populations labelled with rabbit anti-
B. fragilis polyclonal antiserum, secondary
labelled with anti-rabbit FITC-conjugated anti-
body and either mAb QUBf4 (c) or QUBf5 (d),
with secondary labelling using anti-mouse
tetramethyl rhodamine isothiocyanate conju-
gated antibody as detailed by Lutton et al.
(1991).
S. Patrick and others
1040 Microbiology 155
markerless. The ability to complement non-polar deletions
greatly facilitates genetic studies of this important human
commensal and opportunistic pathogen. We also present
direct evidence that two additional loci, PSJ and a region
upstream of PSI, are involved in MC and LC biosynthesis
respectively. These findings have implications for under-
standing how polysaccharides are synthesized in B. fragilis.
METHODS
Strains, plasmids and culture methods. B. fragilis NCTC 9343 was
obtained from the National Collection of Type Cultures, Colindale
Avenue, London, UK. The GenBank accession number for the
genome sequence of B. fragilis NCTC 9343 is NC_003228. E. coli
DH5a (Invitrogen) was used for constructing plasmids using standard
molecular biology protocols. Conjugative vectors for introducing
DNA into B. fragilis were based on pEP185.2 and were mobilized
from the E. coli S17-1lpir strain (Simon et al., 1983). Plasmid pLyl01
(Li et al., 1995) was used to generate the I-SceI-expressing plasmid
pGB920. Plasmid pVA2198 (Fletcher et al., 1995) was used to produce
plasmids containing the locked ON and OFF promoter BF2782
constructs. Media for cultivation of B. fragilis included supplemented
brain heart infusion (BHI-S) and defined medium (DM; van Tassell &
Wilkins, 1978). Cultures were grown in a MACS MG-1000 or Min-
MACS anaerobic workstation (Don Whitley), at 37 uC in an
atmosphere of 80% nitrogen, 10% carbon dioxide and 10%
hydrogen. E. coli was cultured on LB at 37 uC.
Generation of deletion mutants. Approximately 500 bp of DNA
flanking the sequence to be deleted was amplified by PCR using Pfu
polymerase (NEB). Flanking regions were fused to an ermF cassette by
cross-over PCR using Pfu polymerase. PCR products were ligated into
the multiple cloning site of pGB909 (a pEP185.2 derivative containing
an I-SceI recognition sequence inserted at the SacI site). Ligated
products were recovered in an E. coli S17-1lpir strain. Constructs
were mobilized from E. coli S17-1lpir into B. fragilis NCTC 9343
using a filter-mating method (Valentine et al., 1988), followed by
selection on BHI-S plates containing 10 mg erythromycin ml21.
Strains with integrated plasmids were confirmed by PCR and then
electroporated with a derivative of pLyl01 containing the I-SceI
coding region under the control of the B. fragilis fucR promoter, with
selection for resistance to tetracycline. Transformants were streaked
onto DM containing fucose and tetracycline. Colonies were then
screened for resistance to erythromycin and deletion of the
appropriate sequence confirmed by PCR. Markerless deletions were
constructed by ligating cross-over PCR products from just the
flanking regions into pGB910 (a derivative of pGB909 with an ermF
cassette in the KpnI site). Conjugation and selection were as described
above, except the final deletions were screened for loss of resistance to
erythromycin.
Percoll density centrifugation. Discontinuous Percoll gradients
were prepared as previously described (Patrick & Reid, 1983). A
100% stock Percoll (Pharmacia Biosystems) suspension was prepared
by diluting sterile Percoll 9 : 1 with sterile 1.5 M sodium chloride, and
adjusting the pH to 7.0 using 1 M hydrochloric acid. Percoll
suspensions of 20% and 40% (v/v) were prepared by diluting the
100% stock with sterile 0.15 M sodium chloride. Cells grown in DM
were layered on top of the gradients followed by centrifugation at
2375 g for 40 min at 4 uC. Subculture of bacteria separating at and
above the 0–20% interface results in enrichment of the large capsulate
population. Bacteria separating at the 20–40% interface results in
enrichment of the small capsulate population, whereas bacteria that
pass further down the gradient are enriched for the MC.
Immunoblotting of EPS. Immunoblots were prepared as previously
described (Patrick et al., 2003). Aliquots of DM cultures, in late
exponential phase, were resuspended in 1/4 diluted sample buffer
[40% (w/v) glycerol, 0.25 M Tris/HCl pH 6.8, 20% (w/v) b-
mercaptoethanol, 16% (w/v) SDS and 0.04% (w/v) bromophenol
blue] and heated at 100 uC for 10 min. Then 25 mg proteinase K
(Sigma) was added and incubated at 60 uC for 1 h. Digests were
electrophoresed through Novex 10% Tris/glycine polyacrylamide gels
(Invitrogen) in Novex 16 Tris/glycine SDS running buffer (25 mM
Tris base, 192 mM glycine and 0.1% SDS pH 8.3). Polysaccharides
were transferred to nitrocellulose membranes by electroblotting in
transfer buffer [12 mMTris base, 96 mM glycine, 20% (v/v) methanol,
pH 8.3]. Membranes were blocked for 1 h at 37 uC in blocking buffer
[16 TBS, 5% (w/v) dried semi-skimmed milk, 0.05% (v/v) Tween-
20], followed by washing in TBS-0.05% Tween-20 (TBST) at 37 uC.
Membranes were incubated with mAbs QUBf4 (Reid et al., 1987), 5, 6,
7, 8 (Lutton et al., 1991), 11 (Patrick et al., 1995), 18, 19 (Patrick,
1997), 25 (unpublished) and CE3 (Pantosti et al., 1995), for 1 h at
37 uC, followed by washing in TBST at 37 uC. The membrane strips
were incubated for 1 h at 37 uC with either goat anti-mouse IgG
(H+L) alkaline phosphatase conjugate (Bio-Rad) or goat anti-mouse
IgM (m chain specific) alkaline phosphatase conjugate (Sigma). The
membranes were washed in TBST and polysaccharides visualized by
detecting alkaline phosphatase activity using Sigma Fast BCIP/NBT (5-
bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium).
Transformation of B. fragilis NCTC 9343. Overnight cultures of B.
fragilis were diluted in pre-reduced BHI-S broth and grown,
anaerobically at 37 uC, to an OD600 of 0.3. Cells were harvested by
centrifugation at 1610 g for 20 min and washed five times in 20 ml
pre-reduced ultrapure ice-cold water. Cells were finally resuspended
in 1 ml pre-reduced ultrapure ice-cold water. One hundred micro-
litres of cells was used per electroporation in 0.2 cm electrode gene
pulser cuvettes (Bio-Rad). If appropriate, diluted purified bacterio-
phage T7 Ocr (Overcomes classical restriction) protein, kindly gifted
by Dr D. Dryden, School of Chemistry, University of Edinburgh, was
added to the cells at the optimized concentration as detailed below.
Then 500 ng plasmid DNA was added to the cells to give a final
plasmid DNA concentration of 4.0 mg ml21. Electroporation was
performed using a Gene Pulser II electroporator (Bio-Rad) at 2.5 kV
for 5–10 ms. Cells were resuspended in 1 ml pre-reduced 37 uC BHI-
S broth and incubated anaerobically for 2–3 h at 37 uC prior to
plating on BHI-S plates with appropriate antibiotics.
Capsule visualization. B. fragilis possessing LC, SC and MC were
identified using a negative capsule stain (Cruickshank, 1965). A 10 ml
drop of culture was pipetted onto a glass slide. Five microlitres of
carbol fuchsin (Sigma) was added to the bacterial suspension, mixed,
and incubated at room temperature for 30 s. Then 5 ml eosin (Sigma)
was applied and incubated at room temperature for 60 s. The stained
cells were then smeared evenly across the slide using the edge of a
microscope slide and air-dried at room temperature before
visualization by microscopy. Cells and the background stained red,
whereas capsules remain unstained. Transmission electron micro-
scopy of ultrathin sections was carried out as previously described
(Patrick et al., 1986).
Immunofluorescence microscopy (IFM). IFM was performed as
previously described (Patrick et al., 2003). Cultures of B. fragilis
grown in DM broth or BHI-S broth were diluted in sterile PBS to an
OD600 of 0.3. Then 10230 ml was pipetted onto the wells of a 12-well
Teflon-coated slide (ICN Biomedicals) and dried at 37 uC, followed
by fixing with 100% methanol at 220 uC for 20 min. Slides were
brought to room temperature; mAbs were applied to each well and
then incubated at 37 uC for 1 h. Slides were rinsed in a stream of
sterile PBS and washed in a PBS bath for 20 min. Slides were removed
and secondary antibody (goat anti-mouse IgG/IgM-FITC conjugate).
Polysaccharide biosynthesis in Bacteroides fragilis
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Evans blue (0.1%, Sigma), which stains proteins, was also added to
each well as a counter-stain. Slides were then incubated for 1 h at
37 uC. The PBS washing step was repeated, and the slides were
mounted in a glycerol-PBS antibleaching mounting fluid (Citifluor,
Agar Scientific). Cells were examined using a Leitz Ortholux
fluorescence microscope. Images were captured and analysed using
an attached Nikon DMX 1200 digital camera and Lucia G/F software.
RESULTS
Using double-strand break repair to generate
precise deletions in B. fragilis
To facilitate the manipulation of the sequenced strain of B.
fragilis, NCTC 9343, we have adapted the method of Po´sfai
et al. (1999) to allow construction of deletions that are
either marked by an antibiotic resistance determinant or
are markerless. Marked deletion constructs are prepared by
fusing 500 bp sequences from each side of the target gene,
using PCR, to an intervening ermF cassette. The amplicon
is ligated with an RP4-based conjugative vector
(pEP185.2), into which we have inserted an ISce-I
recognition sequence, prior to transformation of an
appropriate E. coli host. The resulting strains are then
conjugated with B. fragilis followed by growth in the
presence of erythromycin to select for integration of the
plasmid (Fig. 2). To resolve the diploid, the strains are
transformed with a plasmid that expresses the ISce-I
meganuclease under the control of the B. fragilis fucR
promoter, followed by growth on a defined medium that
contains fucose. Resolution of the diploid by homologous
recombination follows the ISce-I-mediated double-strand
break and results in production of either the wild-type or
the deletion genotype (Fig. 2). Colonies are then screened
for resistance to erythromycin and the presence of the
deletion confirmed by PCR. The advantage of this method
is that it enhances resolution of the diploid and so most
transformants are either mutant or wild-type; this removes
the need to repeatedly subculture diploid strains and screen
large numbers of colonies for resolution by random
recombination events.
To construct markerless deletions, the sequences flanking
the target gene are fused to each other and the amplicon
ligated to a conjugative plasmid that contains an ermF
cassette and an ISce-I recognition sequence. E. coli strains
containing recombinant plasmids are conjugated with B.
fragilis and integrants are selected by resistance to
erythromycin, followed by resolution of the diploid by
growth in the presence of fucose with subsequent screening
for loss of erythromycin resistance. The resulting strains are
then analysed by PCR to identify mutants containing the
required deletion. The advantages of markerless deletions
are that mutations should not be polar and they can be
Fig. 2. Generation of marked chromosomal deletions in B. fragilis. A suicide plasmid, containing an I-SceI recognition site
(hatched box) and sequences homologous to chromosomal DNA (X and Z) flanking an ermF cassette and replacing the gene to
be deleted (Y), is introduced into B. fragilis by conjugation. Plasmid integrants are selected for resistance to erythromycin.
Diploids are transformed with a plasmid expressing I-SceI under the control of the fucose-inducible promoter PfucR. Growth on
defined medium in the presence of fucose leads to an I-SceI-mediated double-strand break (.) and resolution of the diploid by
generation of either the deletion or wild-type genotypes by homologous recombination. Chromosomal DNA is indicated as
dashed black lines; plasmid DNA is indicated as solid grey lines.
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complemented using plasmids bearing the same antibiotic
resistance determinant, i.e. ermF; this is important since
the natural resistance of B. fragilis to many antibiotics
reduces the number of markers that can be used for
selection.
Transformation has not been previously reported for B.
fragilis NCTC 9343, probably as a result of the multiple R/
M systems specified by the genome. We therefore
determined if the inclusion of purified T7 anti-restriction
protein Ocr acted as a transformation-enhancing co-factor
by inhibiting the action of the extensive endogenous R/M
systems of B. fragilis. The effect of various concentrations
of Ocr protein on the number of transformants was
compared to the transformation efficiency in the absence of
Ocr. Standard electroporations using 500 ng pVA2198
plasmid DNA per transformation, optimized in the absence
of Ocr, generated 1.96104 (±1.96103) transformants per
mg unmodified DNA. The number of transformants
obtained following electroporation increased steadily with
increased Ocr protein concentration, reaching between
5.06105 (±2.56104) and 5.26105 (±2.26104) trans-
formants mg21, corresponding to 16 mg and 8 mg Ocr
protein per plasmid transformation. When Ocr concen-
tration was increased from 16 mg to 32 mg protein per
transformation, a tenfold decrease in transformant num-
bers was observed. An extensive selection of negative
controls and transformant identification tests were per-
formed, confirming that all erythromycin-resistant col-
onies identified were B. fragilis NCTC 9343 transformed
with plasmid pVA2198. Therefore 16 mg purified T7 Ocr
anti-restriction protein (127 mg ml21) was used per
transformation. It has been shown that Ocr protein is
capable of inhibiting type I R/M systems covering a diverse
range of eubacteria and archaea, indicating that the anti-
restriction property of the protein is not dependent on the
target DNA sequence of the type I R/M enzymes (Kru¨ger
et al., 1977, 1983; Walkinshaw et al., 2002), as each type I
system recognizes a unique target DNA sequence
(Titheradge et al., 2001). It is likely that the negative
charge of this DNA mimic allows electroporation of the
protein into the cell, where it is able to reduce the activity
of the resident type I R/M systems (Hoffman et al., 2002;
Dryden, 2006). The all-encompassing type I anti-restriction
activity of Ocr may therefore explain why the protein
appears to be capable of improving transformation
efficiency in B. fragilis NCTC 9343 by counteracting the
DNA-degrading effects of all three complete type I R/M
systems, including the phase-variable system.
Validation of the deletion technique by disruption
of polysaccharide gene cluster PSC
To validate our deletion strategy, we chose to replace the
first gene in PSC, upcY, with an ermF cassette. Krinos et
al. (2001) had previously shown that disruption of upcY,
by insertion of a non-replicating plasmid, prevented
expression of the associated polysaccharide. Expression
of PSC is not controlled by an invertible promoter and its
regulatory mechanisms are currently unknown. However,
the protein encoded by upcY is predicted to contain a
KOW domain and has homology to NusG-like proteins; it
is therefore likely to be involved in anti-termination of
transcription within the leader sequence of the polysac-
charide cluster.
We analysed the DupcY : : ermF strain by immunoblotting,
IFM and negative staining of capsules using a collection of
mAbs that specifically bind to distinct polysaccharides
produced by B. fragilis NCTC 9343 (Patrick et al., 2003;
Fig. 3). Polysaccharides from the wild-type and mutant
strains were prepared by proteinase K digestion of whole
cells followed by electrophoresis through 12–20% poly-
acrylamide gels. Immunoblots, using all mAbs, allowed
detection of characteristic heteropolymorphic, high-
molecular-mass polysaccharides (HMMPS) produced by
the parental strain, as described previously (Lutton et al.,
1991). Polysaccharides derived from the DupcY : : ermF
strain were detectable on immunoblots using eight of the
mAbs, but not QUBf7 (Fig. 3a). Binding of this mAb has
previously been associated with polysaccharides produced
by gene cluster PSC (Coyne et al., 2000). IFM using the
same mAbs confirmed that deletion of upcY led to an
inability to detect cell-surface-associated polysaccharides
that reacted with QUBf7; however, expression of other
polysaccharides was unaffected (Fig. 3b). Both the LC and
SC could be detected by negative staining of capsules (data
not shown), indicating that only production of the PSC
MC was affected by the mutation. It is possible that
insertion of ermF has a polar effect on transcription, which
subsequently leads to this phenotype. Together these data
confirm that deletion of upcY, and its replacement with
ermF, abolishes expression of the PSC gene cluster and
illustrate the effectiveness of the allelic replacement
methodology.
Deletion of BF1708 encoding a putative
polysaccharide copolymerase Wzz homologue
The presence or absence of polysaccharides in B. fragilis
that resemble the classical O-antigen-containing LPS from
E. coli has been the subject of much speculation (Poxton &
Brown, 1986; Lindberg et al., 1990, Lutton et al., 1991).
Dispersed in the NCTC 9343 genome are a number of
‘orphan’ genes that encode putative polypeptides with
homology to proteins known to function in EPS biosyn-
thesis. The original annotation of the genome identified
two potential members of the polysaccharide copolymerase
(PCP) family, encoded by BF1708 and BF2784 (Cerden˜o-
Ta´rraga et al., 2005). No other proteins encoded by B.
fragilis NCTC 9343 can be identified as PCPs using BLAST
searches (E-value cutoff 361024). The assignment of these
two proteins as PCPs is supported by their current
inclusion as the only proteins in B. fragilis within the
InterPro003856 family, which contains 1897 members.
PCPs are divided into three classes based on function and
Polysaccharide biosynthesis in Bacteroides fragilis
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common secondary structural features (Morona et al.,
2000). Gene BF2784 encodes a polypeptide with homology
to proteins of the PCP2 class, for example Wzc proteins
that are involved in capsular biosynthesis (Whitfield,
2006). Gene BF1708, within PS gene cluster J/10, encodes
a putative member of the PCP1 class, which includes Wzz
proteins involved in O-antigen synthesis. Members of this
family often show limited homology but have predicted N-
and C-terminal transmembrane helices separated by a
periplasmic coiled-coil region (Tocilj et al., 2008). The
polypeptide encoded by BF1708 has 20% identity to E. coli
WzzB and is predicted to contain the secondary structure
features associated with PCP1 members. In E. coli the Wzz
protein modulates the polymerase activity of the Wzy
involved in LPS biosynthesis to produce a distinctive
modal distribution of O-antigen chain lengths (Franco et
al., 1998). Although BF1708 encodes the only identifiable
homologue of Wzz in the NCTC 9343 genome, the high
level of sequence divergence within the PCP classes means
that other members might also be present.
To address the nature of the polysaccharide associated with
LPS in B. fragilis and determine if the protein encoded by
BF1708 was involved in LPS biosynthesis, we deleted the
gene by replacing it with an ermF cassette and then
analysed the polysaccharides produced by the mutant. The
introduction of the ermF cassette could have a polar effect
on expression of two downstream genes, BF1709 and
BF1710; however, the products of these two genes are not
likely to be central to polysaccharide production and are
annotated as a putative transcriptional regulator and a
protein of unknown function but with similarity to a
dTDP-4-dehydrorhamnose 3,5-epimerase.
The first obvious phenotype of the D1708 strain was the
bridging flocculation of cells during culture in liquid
medium (Fig. 4a), which may be indicative of altered cell-
surface properties. Microscopy with negative staining for
capsules revealed bacteria with either LC or SC, either
individually or associated with the aggregates composed of
bacteria non-capsulated by light microscopy. Labelling
with a mAb specific for the SC confirmed its presence both
by fluorescence microscopy and immunoblotting of
polysaccharides (not illustrated). Examination of the
capsule smears revealed an irregular capsular phenotype
in approximately 10% of the LC cells (Fig. 4b). This
phenotype has not been observed previously in B. fragilis
and how it relates to the deletion of BF1708 is open to
speculation. Immunoblotting of MC polysaccharides
produced by the D1708 strain indicated that this culture
was not antigenically mixed but was predominantly
expressing a single polysaccharide that reacted with mAb
QUBf5, which is specific for polysaccharides synthesized by
the PSD locus (Fig. 4c). The blot pattern for the
polysaccharide was, however, clearly distinct from that of
the parental strain and other mutants, such as the DupcY
strain, which show HMMPS and an associated ladder
similar to that previously described (Lutton et al., 1991;
Fig. 4c); in the D1708 mutant the HMMPS was absent and
Fig. 3. Analysis of polysaccharide production in the DupcY strain.
(a) Examples of immunoblots probed with mAbs specific for
polysaccharides produced by B. fragilis NCTC 9343 are shown
on the left side, with the position of HMMPS indicated adjacent to
the blots. Immunoblots of polysaccharides from the DupcY strain are
shown on the right side. A protein molecular mass ladder is provided
to give an indication of the relative migration of polysaccharides
during electrophoresis. mAbs which react with specific polysac-
charides are: QUBf25 (PSB); QUBf5 (PSD); CE3 (PSA); QUBf7
(PSC). (b) Examples of IFM analysis of polysaccharides produced
by the DupcY strain. Panels on the left represent fluorescent
labelling of mAbsQUBf18 (PSB), QUBf7 (PSC) andQUBf5 (PSD),
while panels on the right show total cells in the same field of view
stained with Evans blue. An example of IFM using QUBf7 labelling
wild-type NCTC 9343 is shown at the bottom.
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a lower-molecular-mass ladder pattern was evident (Fig.
4c). The loss of HMMPS D in the D1708 strain is
supported by the reduction in reactivity with mAb QUBf5
by IFM (Fig. 4d). The inability to detect HMMPS produced
by the other loci, using immunoblotting and IFM, does not
rule out the possibility that the polysaccharides are still
present as short-chain repeats, which would reflect a
reduced sensitivity of the mAbs for the residual repeat
units. Together, these data indicate that deletion of the
putative wzz gene and replacement with ermF prevents
assembly of HMMPS synthesized by the PSD gene cluster
into a long-chain-length polymer attached to the cell
surface and that other HMMPS associated with the MC are
not detectable.
Deletion of BF2782 encoding a putative
polysaccharide export protein involved in
synthesis of the large capsule
Phase variation with respect to capsule production in B.
fragilis was first reported by Patrick & Reid (1983) when
they described the separation of bacteria expressing
capsules of different sizes using centrifugation through
Percoll step gradients. While expression of seven EPS
associated with the MC are regulated by site-specific
recombination, little is known about the genes or the
regulation of LC or SC production; clearly from the data
presented above, the putative Wzz encoded by BF1708 is
not involved. Annotation of the NCTC 9343 genome,
however, identified a further set of orphan genes which are
potentially involved in polysaccharide biosynthesis. ORFs
BF2782 and BF2784 may encode homologues of the WbaP
and Wzc proteins, which are involved in group 1 and 4
capsule synthesis in E. coli. WbaP is part of a glycosyl-
transferase complex involved in formation of lipid-linked
precursors in the cytoplasm prior to translocation across
the inner membrane, while Wzc (a member of the PCP2
family) is a membrane-bound protein that modulates the
activity of the cognate Wzy polymerase. The promoter
upstream of BF2782 was reported to be invertible and its
orientation was reported to correlate with production of
the LC, as shown by deletion of a tyrosine site-specific
recombinase, tsr19 (Chatzidaki-Livanis et al., 2008). These
authors, however, cultured their isolates in a complex basal
medium that fails to reveal the LC phenotype and therefore
does not distinguish between the antigenically different LC
and SC. The LC and SC phenotypes are clearly evident on
culture in defined medium (DM) by light microscopy (Fig.
1; Patrick & Reid, 1983; Patrick et al., 1986) and are
antigenically distinct (Reid et al., 1987). LC and SC bacteria
can be separated using a discontinuous Percoll density
gradient where the LC population does not enter into the
20% Percoll, but remains at the top of the gradient after
centrifugation, whereas the SC cells locate at the 20–40%
interface layer (Fig. 5a) The MC cells pass through the
gradient to the 60–80% interface (Patrick et al., 1986).
Capsule staining of wild-type cells from the 0–20%
interface shows enrichment of cells expressing the LC,
which are visually distinct from the SC population derived
from the 20–40% interface (Fig. 5a). The Percoll gradients
used to fractionate the tyrosine site-specific recombinase
mutant illustrated by Chatzidaki-Livanis et al. (2008) show
that the mutant with the ‘locked ON’ promoter has entered
into the 20% Percoll suspension, and therefore it is not
Fig. 4. Phenotypic analysis of the D1708/wzz
strain. (a) Liquid cultures of B. fragilis NCTC
9343 and the D1708/wzz strain grown over-
night. Note the aggregation of cells at the
bottom of the tubes containing the D1708/wzz
strain. (b) Negative staining of LC-producing
cells from NCTC 9343 (left panels) and the
D1708/wzz strain (right panels). Note the
atypical protrusion of capsules from the
D1708/wzz strain. (c) Immunoblots using
QUBf5 (PSD) against polysaccharides derived
from NCTC 9343, DupcY and D1708/wzz.
The relative positions of HMMPS and the
smaller polysaccharide repeat units are shown
adjacent to the blots. A protein molecular mass
ladder is shown as an indication of the relative
migration of polysaccharides during electro-
phoresis. (d) Combined IFM image of mAb
QUBf5 labelling (green) and Evans blue total
cell labelling (red) of the D1708/wzz strain.
Note the presence of large aggregates of cells
but the low-level detection of polysaccharides
produced by the PSD locus.
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clear whether the LC or SC has been affected by the
deletion. The negative staining of cells with the locked ON
promoter reported by Chatzidaki-Livanis et al. (2008) also
did not display a capsule that correlated with the previously
described characteristics of the LC (Patrick & Reid, 1983;
Patrick et al., 1986; Reid et al., 1987; Lutton et al., 1991).
To determine directly the role of BF2782 in production of
either the LC or SC, we therefore generated both marked
and markerless deletions of the gene. Replacement of
BF2782 with an ermF cassette resulted in a mutant that was
unable to synthesize the LC, as shown by the failure of cells
to remain on top of 20% Percoll after centrifugation. This
was confirmed by capsule staining of bacteria grown in DM
followed by microscopy, which failed to detect any cells
producing the LC (data not shown). IFM (Fig. 5b) and
PAGE followed by immunoblotting (data not shown) of
the DBF2782 mutant using a suite of MC-specific mAbs
indicated that deletion of BF2782 had not affected
expression of the multiple-variable MC. Since insertion
of ermF may have been polar, we analysed the strain
containing a markerless deletion of BF2782 using the same
methods. The markerless mutant did not produce cells that
remained on top of the 20% Percoll after centrifugation
(Fig. 5c), and again we could not detect any cells expressing
the LC by capsule staining (data not shown). SC bacteria
were, however, evident at the 20–40% interface (Fig. 5c),
and reaction with a mAb specific for the SC (Reid et al.,
1987) was positive by IFM (Fig. 5b). To confirm that the
markerless deletion was responsible for the loss of LC
production, we complemented the mutation by expressing
BF2782 from a plasmid-borne copy of the gene. Two
plasmids containing the BF2782 ORF were constructed:
one had the invertible promoter locked ON while the other
was always OFF. Only transformation of the D2782 strain
with the ON promoter construct enabled the cells to
produce the LC, as determined by their presence on the 0–
20% Percoll interface (data not shown) and capsule
staining (Fig. 5d). Expression of the LC in this strain had
Fig. 5. Phenotypic analysis of LC production in the D2782 strain. (a) Discontinuous Percoll density gradient (20 and 40%
Percoll) used to separate the LC, SC and MC populations of B. fragilis NCTC 9343 grown in defined medium. Micrographs
showing negative staining of the antigenically distinct LC and SC capsules are presented on the left. The LC population
remained on top of the 0–20% interface while the SC population remained at the 20–40% interface. (b) Examples of IFM
images of mAb QUBf4 and QUBf5 labelling demonstrating that expression of SC and MC, respectively, is not altered in the
D2782 strain. (c) Discontinuous Percoll density gradient (20 and 40% Percoll) showing the fractionation of cells expressing the
SC and MC from the D2782 strain. There is no evidence of cells expressing the LC, which are expected to remain at the 0–
20% interface. (d) Micrographs showing negative staining used to visualize LC production in the D2782 strain containing
plasmids with the promoter for BF2782 in either the ‘OFF’ or ‘ON’ orientation, grown in defined medium. Examples of cells
expressing the LC in the complemented strain are indicated by arrows.
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also returned to being phase variable, as only a fraction of
the population produced the LC. This observation
indicates that the invertible promoter on the chromosome
of the markerless D2782 strain was switching the expression
of the remaining downstream gene(s) on and off, and
implies that either BF2783 or BF2784, or both, are also
involved in LC production.
DISCUSSION
The nature of LPS in B. fragilis has been the subject of much
speculation and controversy (reviewed by Patrick, 2002). It
is clearly different from the paradigm of classical enteric LPS;
for example, lipid A diglucosamine in B. fragilis is
monophosphorylated rather than bisphosphorylated.
While all the genes necessary to synthesize keto-deoxyocto-
nate (KDO) are present in the genome of NCTC 9343, its
chemical composition is different from enteric KDO since it
appears to be phosphorylated, thus rendering it undetectable
in the standard thiobarbituric acid assay (Beckmann et al.,
1989). A major question, however, remains over the
presence or absence of a polysaccharide that resembles an
enteric O-antigen. Lindberg et al. (1990) stated that the
repeating unit of an O-antigen is not present in B. fragilis,
while Poxton & Brown (1986) clearly demonstrated that a
polysaccharide with a repeat size equivalent to enteric O-
antigen could be detected in at least one B. fragilis strain.
Subsequently Lutton et al. (1991) described a within-strain
antigenically variable HMMPS with an associated O-
antigen-like ladder pattern after PAGE and immunoblot-
ting, which was later designated PSD (Patrick et al., 2003).
The genome of B. fragilis NCTC 9343 appears to be devoid
of an operon with genetic structure similar to the loci
involved in synthesis of O-antigen or lower-molecular-
mass lipid A-linked K-antigen (termed KLPS) in E. coli.
However, a single gene encoding a protein with homology
to an O-antigen copolymerase, Wzz, was identified in B.
fragilis. The Wzz protein in E. coli determines the modal
distribution of O-antigen/KLPS chain length, and deletion
of the wzz gene simply produces unregulated lengths of
polysaccharide chains. In group 1 and 4 K-antigens, for
example, serotype K40, which forms both lipid A-linked
KLPS and high-molecular-mass non-lipid A-linked capsular
(K)-antigen, there is no loss of higher-molecular-mass K-
antigen when wzz is deleted. Deletion of BF1708 produced
an unexpected phenotype whereby the HMMPS represent-
ing the MC were not detectable by immunoblotting using
mAbs. This phenotype is similar to that described by
Coyne et al. (2008) following deletion of a gene encoding a
UDP-GlcNAc 4,6-dehydratase (BF1706), where the strain
failed to produce polysaccharides associated with the MC
and also underwent aggregation. It is hypothesized that the
dehydratase is responsible for synthesizing the unusual
sugar residues found in B. fragilis polysaccharides.
Although both BF1706 and BF1708 seem to be involved
in HMMPS biosynthesis, it is not clear if they are part of an
operon since BF1706 is separated from BF1707 by 120 bp.
The loss of HMMPS in the B. fragilis Dwzz/1708 mutant is
very different from the change in distribution of O-antigen
chain lengths in an E. coli wzz mutant, which was shown to
be random and contained both larger and smaller numbers
of repeat units compared to the wild-type (Franco et al.,
1998). The demonstration that a Wzz homologue is
involved in controlling polysaccharide chain length also
suggests that PSD and the other MC-associated poly-
saccharides may be covalently linked to lipid A-core. In
group 1 or 4 capsules, lipid A-linked KLPS usually only
represents a small proportion of total capsular polysac-
charide, with most being anchored to an unknown moiety
on the cell surface as capsular or K-antigen. This would
therefore make the antigenically variable MC-associated
polysaccharides the equivalent of enteric LPS, but with a
higher-molecular-mass polysaccharide that forms the
electron-dense layer visible by electron microscopy on the
exterior of the cell. Some strains of E. coli do produce very
long-chain-length O-antigen polysaccharides, for example
E. coli O157 (Sheng et al., 2008); however, these polymers
are still shorter than the HMMPS present in B. fragilis MC.
A high-molecular-mass LPS in B. fragilis would be
consistent with the findings of Lindberg et al. (1990). We
also hypothesize that the one B. fragilis strain (NCTC
9344), which Poxton & Brown (1986) found to express LPS
with short repeat units, potentially contained a mutation in
wzz. This would be consistent with the short polymer
repeat units that we observed on the immunoblots of the
Dwzz/1708 strain. Whether or not the MC polysaccharide is
anchored to the lipid A, and therefore equivalent to a high-
molecular-mass LPS, could be tested by deleting the gene
encoding the ligase that attaches the polysaccharide to lipid
A-core; however, homologues of waaL have yet to be
identified in the genome. Nevertheless, the MC polysac-
charide is present in LPS prepared using, for example,
aqueous phenol extraction methods (Delahooke et al.,
1995).
Three different capsule types were originally identified in B.
fragilis: MC, LC and SC (Patrick et al., 1986). If the MC is
anchored to lipid A-core and equivalent to a high-
molecular-mass KLPS, then are the LC and SC equivalent
to E. coli groups 1 and 4, and related colanic acid, capsules?
Association of mAb binding with expression of specific
polysaccharide gene clusters has narrowed the focus to
potential candidate genes involved in LC and SC
formation. The genome sequencing project annotated
three genes (BF2782–2784) encoding homologues of
proteins potentially involved in group 1 and 4 capsule
synthesis (Cerden˜o-Ta´rraga et al., 2005). An invertible
promoter has been identified upstream of these three
genes, and deletion of the tyrosine recombinase that
mediates inversion of the promoter has allowed expression
to be locked either in the ON or OFF conformation
(Chatzidaki-Livanis et al., 2008). The OFF position
correlated with loss of capsule visible by light microscopy.
These authors, however, used a complex medium in which
the LC is not distinguishable from the SC by light
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microscopy or Percoll gradient centrifugation (Patrick &
Reid, 1983). We tested directly the hypothesis that BF2782
was involved in LC formation by deleting the gene and
then complementing the mutation with a plasmid-borne
copy of the gene. Deletion of BF2782 prevented the
synthesis of the LC as determined by Percoll gradient
centrifugation and capsule staining. The SC, however, was
still expressed and this was confirmed by mAb labelling.
Complementation of the non-polar markerless deletion
resulted in phase-variable expression of the LC, even when
BF2782 was constitutively expressed. This observation
suggests that inversion of the promoter controlling
expression of BF2783 and BF2784 in the D2782 strain
was responsible for switching OFF expression and therefore
implicates these genes in expression of the LC. The
predicted protein encoded by BF2784 has homology to
Wzc, which modulates the polymerase activity of the Wzy
protein, and BF2783 has homology to Wza, a member of
the outer-membrane auxiliary (OMA) protein family,
which forms multimeric channels involved in polysacchar-
ide extrusion. From these data we infer that assembly of the
LC in B. fragilis is equivalent enzymically to production of
colanic acid, group 1 and 4 K-antigen capsules in E. coli,
whereas the MC are assembled by an entirely independent
mechanism similar to that of KLPS. B. fragilis is therefore
unusual not just in the number and variety of different
polysaccharide capsule loci present in an individual strain,
but also potentially in the nature of the LPS anchored at
the cell surface. While the role of the LC in avoidance of
phagoctyic uptake and killing and the MC in resistance to
serum killing has been reported (Reid & Patrick, 1984), the
relative importance of these structures and the SC in
survival in the human gastrointestinal tract remains to be
determined.
ACKNOWLEDGEMENTS
We are grateful to David Dryden, School of Chemistry, Edinburgh
University, for the generous gift of purified T7 Ocr, to Laurie
Comstock for supplying mAb CE3, Nadja Shoemaker for pLyl01,
Joseph Aduse-Opoku for pVA2198 and Caroline Miles for pEP185.2.
S. H. was in receipt of a Department of Employment and Learning
Northern Ireland Studentship. Z. T. was supported by a BBSRC grant
(BB-C505875-1) awarded to G.W. B.
REFERENCES
Baughn, A. D. & Malamy, M. H. (2002). A mitochondrial-like
aconitase in the bacterium Bacteroides fragilis: implications for the
evolution of the mitochondrial Krebs cycle. Proc Natl Acad Sci U S A
99, 4662–4667.
Beckmann, I., van Eijk, H. G., Meisel-Mikolajczyk, F. & Wallenburg,
H. C. (1989). Detection of 2-keto-3-deoxyoctonate in endotoxins
isolated from six reference strains of the Bacteroides fragilis group. Int
J Biochem 21, 661–666.
Begg, K. J. & Donachie, W. D. (1978). Changes in cell size and shape
in thymine-requiring Escherichia coli associated with growth in low
concentrations of thymine. J Bacteriol 133, 452–458.
Cerden˜o-Ta´rraga, A. M., Patrick, S., Crossman, L. C., Blakely, G.,
Abratt, V., Lennard, N., Poxton, I., Duerden, B., Harris, B. & other
authors (2005). Extensive DNA inversions in the Bacteroides fragilis
genome control variable gene expression. Science 307, 1463–1465.
Chatzidaki-Livanis, M., Coyne, M. J., Roche-Hakansson, H. &
Comstock, L. E. (2008). Expression of a uniquely regulated
extracellular polysaccharide confers a large-capsule phenotype to
Bacteroides fragilis. J Bacteriol 190, 1020–1026.
Coyne, M. J., Kalka-Moll, W., Tzianabos, A. O., Kasper, D. L. &
Comstock, L. E. (2000). Bacteroides fragilis NCTC9343 produces at
least three distinct capsular polysaccharides: cloning, characterization,
and reassignment of polysaccharide B and C biosynthesis loci. Infect
Immun 68, 6176–6181.
Coyne, M. J., Weinacht, K. G., Krinos, C. M. & Comstock, L. E. (2003).
Mpi recombinase globally modulates the surface architecture of a
human commensal bacterium. Proc Natl Acad Sci U S A 100, 10446–
10451.
Coyne, M. J., Chatzidaki-Livanis, M., Paoletti, L. C. & Comstock, L. E.
(2008). Role of glycan synthesis in colonization of the mammalian gut
by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci U S A
105, 13099–13104.
Cruickshank, R. (1965). Medical Microbiology: a Guide to the
Laboratory Diagnosis and Control of Infection, 11th edn, pp. 657–
660. Edinburgh: E. & S. Livingstone Ltd.
Delahooke, D. M., Barclay, G. R. & Poxton, I. R. (1995). A re-appraisal
of the biological activity of Bacteroides LPS. J Med Microbiol 42, 102–
112.
Dryden, D. T. (2006). DNA mimicry by proteins and the control of
enzymatic activity on DNA. Trends Biotechnol 24, 378–382.
Fletcher, H. M., Schenkein, H. A., Morgan, R. M., Bailey, K. A., Berry,
C. R. & Macrina, F. L. (1995). Virulence of a Porphyromonas gingivalis
W83 mutant defective in the prtH gene. Infect Immun 63, 1521–1528.
Franco, A. V., Liu, D. & Reeves, P. R. (1998). The wzz (cld) protein in
Escherichia coli: amino acid sequence variation determines O-antigen
chain length specificity. J Bacteriol 180, 2670–2675.
Hoffman, L. M., Haskins, D. J. & Jendrisak, J. (2002). Type I inhibitor
improves transformation efficiencies by blocking type I restriction
and modification systems in vivo. EPICENTRE Forum 9, 8.
Krinos, C. M., Coyne, M. J., Weinacht, K. G., Tzianabos, A. O., Kasper,
D. L. & Comstock, L. E. (2001). Extensive surface diversity of a
commensal microorganism by multiple DNA inversions. Nature 414,
555–558.
Kru¨ger, D. H., Schroeder, C., Hansen, S. & Rosenthal, H. A. (1977).
Active protection by bacteriophages T3 and T7 against E. coli B- and
K-specific restriction of their DNA. Mol Gen Genet 153, 99–106.
Kru¨ger, D. H., Hansen, S. & Reuter, M. (1983). The ocr+ gene
function of bacteriophages T3 and T7 counteracts the Salmonella
typhimurium DNA restriction systems SA and SB. J Virol 45, 1147–
1149.
Li, L. Y., Shoemaker, N. B. & Salyers, A. A. (1995). Location and
characteristics of the transfer region of a Bacteroides conjugative
transposon and regulation of transfer genes. J Bacteriol 177, 4992–
4999.
Lindberg, A. A., Weintraub, A., Za¨hringer, U. & Rietschel, E. T. (1990).
Structure-activity relationships in lipopolysaccharides of Bacteroides
fragilis. Rev Infect Dis 12 (Suppl. 2), S133–S141.
Liu, C. H., Lee, S. M., Vanlare, J. M., Kasper, D. L. & Mazmanian, S. K.
(2008). Regulation of surface architecture by symbiotic bacteria
mediates host colonization. Proc Natl Acad Sci U S A 105, 3951–3956.
Lutton, D. A., Patrick, S., Crockard, A. D., Stewart, L. D., Larkin, M. J.,
Dermott, E. & McNeill, T. A. (1991). Flow cytometric analysis of
S. Patrick and others
1048 Microbiology 155
within-strain variation in polysaccharide expression by Bacteroides
fragilis by use of murine monoclonal antibodies. J Med Microbiol 35,
229–237.
Morona, R., Van Den Bosch, L. & Daniels, C. (2000). Evaluation of
Wzz/MPA1/MPA2 proteins based on the presence of coiled-coil
regions. Microbiology 146, 1–4.
Pantosti, A., Colangeli, R., Tzianabos, A. O. & Kasper, D. L. (1995).
Monoclonal antibodies to detect capsular diversity among Bacteroides
fragilis isolates. J Clin Microbiol 33, 2647–2652.
Patrick, S. (1993). The virulence of Bacteroides fragilis. Rev Med
Microbiol 4, 40–49.
Patrick, S. (1997). Variation in Bacteroides fragilis surface structures.
In Anaerobic Pathogens, pp. 19–30. Edited by A. R. Eley & K. W.
Bennet. Sheffield: Sheffield Academic Press.
Patrick, S. (2002). Bacteroides. In Molecular Medical Microbiology, pp.
1921–1948. Edited by M. Sussman. London: Academic Press.
Patrick, S. & Duerden, B. I. (2006). Gram-negative non-spore forming
obligate anaerobes. In Principles and Practice of Clinical Bacteriology,
pp. 541–556. Edited by S. H. Gillespie & P. Hawkey. London: Wiley.
Patrick, S. & Reid, J. H. (1983). Separation of capsulate and non-
capsulate Bacteroides fragilis on a discontinuous density gradient. J
Med Microbiol 16, 239–241.
Patrick, S. J., Reid, J. H. & Coffey, A. (1986). Capsulation of in vitro
and in vivo grown Bacteroides species. J Gen Microbiol 132, 1099–
1109.
Patrick, S., Stewart, L. D., Damani, N., Wilson, K. G., Lutton, D. A.,
Larkin, M. J., Poxton, I. & Brown, R. (1995). Immunological detection
of Bacteroides fragilis in clinical samples. J Med Microbiol 43, 99–109.
Patrick, S., Parkhill, J., McCoy, L., Lennard, N., Larkin, M.,
Sczaniecka, M. & Blakely, G. (2003). Multiple inverted DNA repeats
of Bacteroides fragilis that control polysaccharide antigenic variation
are similar to the hin region inverted repeats of Salmonella
typhimurium. Microbiology 149, 915–924.
Po´sfai, G., Kolisnychenko, V., Bereczki, Z. & Blattner, F. R. (1999).
Markerless gene replacement in Escherichia coli stimulated by a
double-strand break in the chromosome. Nucleic Acids Res 27, 4409–
4415.
Poxton, I. R. & Brown, R. (1986). Immunochemistry of the surface
carbohydrate antigens of Bacteroides fragilis and definition of a
common antigen. J Gen Microbiol 132, 2475–2481.
Redondo, M. C., Arbo, M. D., Grindlinger, J. & Snydman, D. R. (1995).
Attributable mortality of bacteremia associated with the Bacteroides
fragilis group. Clin Infect Dis 20, 1492–1496.
Reid, J. H. & Patrick, S. (1984). Phagocytic and serum killing of
capsulate and non-capsulate Bacteroides fragilis. J Med Microbiol 17,
247–257.
Reid, J. H., Patrick, S. & Tabaqchali, S. (1987). Immunochemical
characterization of a polysaccharide antigen of Bacteroides fragilis with
an IgM monoclonal antibody. J Gen Microbiol 133, 171–179.
Salyers, A. A., Bonheyo, G. & Shoemaker, N. B. (2000). Starting a
new genetic system: lessons from Bacteroides. Methods 20, 35–46.
Sheng, H., Lim, J. Y., Watkins, M. K., Minnich, S. A. & Hovde, C. J.
(2008). Characterization of an Escherichia coli O157 :H7 O-antigen
deletion mutant and effect of the deletion on bacterial persistence in
the mouse intestine and colonization at the bovine terminal rectal
mucosa. Appl Environ Microbiol 74, 5015–5022.
Simon, R., Priefer, U. & Pu¨hler, A. (1983). Broad host range
mobilization system for in vivo genetic engineering: transposon
mutagenesis in gram negative bacteria. Biotechnology 1, 784–791.
Sutherland, I. W. (1977). Surface Carbohydrates of the Prokaryotic Cell.
London: Academic Press.
Titheradge, A. J., King, J., Ryu, J. & Murray, N. E. (2001). Families of
restriction enzymes: an analysis prompted by molecular and genetic
data for type ID restriction and modification systems. Nucleic Acids
Res 29, 4195–4205.
Tocilj, A., Munger, C., Proteau, A., Morona, R., Purins, L., Ajamian, E.,
Wagner, J., Papadopoulos, M., Van Den Bosch, L. & other authors
(2008). Bacterial polysaccharide co-polymerases share a common
framework for control of polymer length. Nat Struct Mol Biol 15, 130–
138.
Valentine, P. J., Shoemaker, N. B. & Salyers, A. A. (1988).
Mobilization of Bacteroides plasmids by Bacteroides conjugal ele-
ments. J Bacteriol 170, 1319–1324.
van Tassell, R. L. & Wilkins, T. D. (1978). Isolation of auxotrophs of
Bacteroides fragilis. Can J Microbiol 24, 1619–1621.
Vimr, E. R. & Steenbergen, S. M. (2006). Mobile contingency locus
controlling Escherichia coli K1 polysialic acid capsule acetylation. Mol
Microbiol 60, 828–837.
Walkinshaw, M. D., Taylor, P., Sturrock, S. S., Atanasiu, C., Berge, T.,
Henderson, R. M., Edwardson, J. M. & Dryden, D. T. (2002). Structure
of Ocr from bacteriophage T7, a protein that mimics B-form DNA.
Mol Cell 9, 187–194.
Whitfield, C. (2006). Biosynthesis and assembly of capsular poly-
saccharides in Escherichia coli. Annu Rev Biochem 75, 39–68.
Edited by: V. Eijsink
Polysaccharide biosynthesis in Bacteroides fragilis
http://mic.sgmjournals.org 1049
